Braemar Hotels & Resorts (BHR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Achieved 4.2% year-over-year comparable RevPAR growth to $404 in Q1 2025, with ADR up 4.5% to $626 and occupancy steady at 64.6%; both urban and resort hotels contributed, with urban hotels seeing 11.3% RevPAR growth and resorts nearly 2%.
Comparable hotel EBITDA for Q1 2025 was $70.8 million, up 5.3% year-over-year.
Net loss attributable to common stockholders was $(2.5) million, or $(0.04) per diluted share.
Adjusted FFO per diluted share was $0.40; Adjusted EBITDAre was $63.0 million.
Redeemed $26.2 million of non-traded preferred stock in Q1, totaling $90 million redeemed to date.
Financial highlights
Comparable total hotel revenue was $218.4 million, up 4.2% year-over-year; comparable hotel EBITDA margin improved to 32.4%.
Net debt to gross assets stood at 42.3% as of Q1 end.
Cash and cash equivalents at quarter-end were $81.7 million, with $54.5 million in restricted cash.
Capex invested in Q1 was $15.3 million.
Quarterly dividend maintained at $0.05 per share, annualized yield of 10.4%.
Outlook and guidance
Group room revenue pace for 2025 up 7%, with 2026 showing 10% growth; industry forecasts project luxury RevPAR growth of 5.0% in 2025.
Anticipated 2025 capital expenditures between $75 million and $95 million, including major renovations and conversions.
Board declared a $0.05 per share quarterly dividend for Q2 2025, with intent to review and potentially increase as performance improves.
Management expects continued outperformance, citing portfolio positioning and operational improvements.
Latest events from Braemar Hotels & Resorts
- Brancous seeks five Board seats to oversee Ashford’s exit, hotel sales and proceeds.BHR
Proxy filing - Self-management and a seven-hotel luxury focus target $88M midpoint 2027 Adjusted EBITDAre.BHR
Investor presentation - Settlement ends the proxy challenge and imposes a 10-year standstill and shared costs.BHR
Proxy filing - Record RevPAR and EBITDA growth in Q2 2026, led by luxury resorts and major asset sales.BHR
Q2 2026 - Transition to self-management and board overhaul gains investor backing amid governance scrutiny.BHR
Proxy filing - Record AFFO per share, strong EBITDA growth, and a $176M asset sale highlight Q1 2026.BHR
Q1 2026 - 2025 saw modest RevPAR growth, net loss, and a sale process, with resorts outperforming.BHR
Q4 2025 - Urban hotels outperformed as asset sales and refinancing strengthened the balance sheet.BHR
Q2 2024 - Q4 RevPAR rose 1.9% with strong bookings and a positive 2025 outlook.BHR
Q4 2024